Issue link: http://osercommunicationsgroup.uberflip.com/i/709452
C h a i n D r u g s t o r e D a i l y S u n d a y, A u g u s t 7 , 2 0 1 6 1 4 CETAPHIL HAS NEW LOOK, EXPANDS INTO MEN'S SKINCARE It's been 69 years since a leading phar- macist created the first Cetaphil product – a gentle yet powerful formula that would clean without stripping and mois- turize without clogging. Today, Cetaphil has garnered more than 115 awards and is recommended by more dermatologists than any other brand of cleansers and moisturizers and is recognized around the world. With leading global skincare experts, Cetaphil continues to innovate in skincare. In the first half of this year, the brand has made two newsworthy changes. In February 2016, Cetaphil Men was launched, offering an extensive line of solutions to clean, moisturize and protect men's skin. "Cetaphil has been a trusted brand by consumers and dermatologists for decades, the introduction of Cetaphil ® Men further amplifies the Cetaphil Brand's mission to provide the most effective and comprehensive skin care products to the consumer. With the growth of the men's grooming category, a line for men was the next phase in offering targeted skin care," says Miles Harrison, President and General Manager at Galderma for North America. Built for all skin types, including dry or sensitive skin, the entire Cetaphil Men line is dermatologist rec- ommended, non-irritating and leaves out harsh ingredients and heavy fragrances to promote healthy skin on a daily basis. In April of this year, Cetaphil announced a full graphics and packaging update to its core line of products. The aim of the new look is to provide a more simplified shopping experience at shelf, improved portfolio differentiation, as well as clarity of product ben- efits. The more modern look includes distinction between cleansers and moisturizers – with blue and green caps, respectively – as well as clear skin type communication based on consumer and shopper testing. "For 69 years, Cetaphil has helped consumers improve the way they care for their skin," says Harrison. "In turn, we want to improve their shopping experi- ence." Cetaphil is certainly a brand to watch as it continues to expand and inno- vate into new categories. For more information, visit booth #909. PRASCO COMMITTED TO ITS UNLIMIT PHILOSOPHY Prasco is an independent, innovative healthcare company dedicated to expand- ing horizons for its pharmaceutical part- ners, pharmacy customers and the patients they serve. Industry-leading companies turn to Prasco for its industry insight, specialized expertise and turnkey solutions for bringing high-quality Authorized Generics (AG) to market. Prasco's business model puts its partners squarely in the center of every- thing the company does. Prasco's Unlimit ® philosophy has helped the com- pany and its partners achieve notable industry success (75 AG products launched with 44 different brand compa- nies) throughout the past decade. To unlimit is to break through barriers and to unlock potential, to introduce new solu- tions and to open broader avenues. When limits are removed, business can have explosive growth. With a deep understanding of all facets of the pharmaceutical marketplace in both the brand and generic industries, Prasco can unlimit partners in a variety of ways. Below, three of these ways are fur- ther discussed. Create Markets Long-standing business relationships within all trade classes provide Prasco insight on how sales interactions best occur across multiple levels. Utilizing this knowledge, Prasco designs and implements proprietary sales programs to fit partners'—and their c u s t o m e r s ' — s p e c i f i c requirements. By extending brand product lifecycles through Authorized Generics, Prasco builds markets that previously did not exist. Doing this enables Prasco's partners to penetrate the marketplace, capturing rev- enue that would not otherwise be avail- able. At the same time, Authorized Generics provide pharmacists and their patients the identical brand-quality expe- riences they want and deserve. Enhance Value Prasco's team is comprised of top talent from around the industry, and this team's purpose is not only to lead Prasco but also to serve Prasco's partners by sharing knowledge and working closely with their management teams. Prasco adds value to its partners by augment- ing partners' capacity to manage all pharmaceutical disciplines and functions, from sourcing active ingredients to sales and marketing. For pharmacists and patients, Prasco adds value through first-to- market products, pristine quality, competitive pricing, consistent supply and uncompromising customer service. Amplify Potential Prasco builds relationships centered upon trust, and the company is committed to excellence in all facets of its business. This combination of trustworthiness and excellence results in the creation of new synergies and scenarios for partners and customers that both activate growth and benefit the entire marketplace. For more information, visit booth #617 or go to www.prasco.com. WESTROCK PROVIDES SUPPORT FOR RETAIL PHARMACY CHALLENGES WestRock provides pharmacies and phar- maceutical manufacturers with unique, award-winning packaging solutions that are designed to improve patient adher- ence to medication, enhance pharmacy efficiencies and increase speed to market. Shellpak ® Renew and Doseapak ® , top-selling adherence solutions, protect medication integrity and offer superior child safety (F=1), while remaining easy for adults to use. An innovative capabili- ty under the new organization is mer- chandising displays, which help drive promotion at the retail setting with tem- porary promotional and permanent point- of-purchase displays. Providing end-to-end marketing, merchandising and packaging suite of solutions, WestRock supports the retail pharmacy's challenges comprehensively. Adherence packaging solutions not only maximize pharmacist-patient interaction opportunities, but also provide increased opportunities to satisfy CMS Star ratings and boost reimburse- ment. Merchandising displays amplify the investment many retail pharmacies have made in mobile app technology, in-store promotions and point of sale prospects by creating a uni- fied customer experience. The Patient/Consumer Journey Your patient enters the retail store to pick up a prescription from the pharmacy. Notifications of in-store promotions appear on the patient's mobile device through the retail app. The patient makes a note to pick up the allergy medication being promoted, after remembering his son's allergy attack the night before. The patient proceeds to the pharmacy where he has a meaning- ful educational interaction with the phar- macist, who explains his cholesterol medication regimen and side effects, and the importance of compliance to maxi- mize symptom improvement. The patient then goes to pick up Allergy Med X from the WestRock display. He also pulls an in-store coupon off the display for $2 off tissues, finishes his shopping and pro- ceeds to checkout. Visit WestRock at booth #1009. ASCEND LOOKS TO GROW BENZONATATE POSITION Two cough and cold seasons ago, Ascend found itself, unexpectedly, as the only sup- plier of Benzonatate on the market. Two other suppliers had left the market for dif- ferent issues. That left Ascend to supply the entire market at a time when several dynamics conspired together to dramati- cally increase the demand for Benzonatate. Those dynamics included the FDA changing the rules for physicians calling in prescriptions for Rx cough syrups. No longer can a physician call these in over the phone, and refills are not permitted. This process has made many physicians turn to Benzonatate for cough control because of its non-narcotic profile and ease of use. Demand was further impact- ed by flu seasons that were significantly more severe in parts of the country than the preceding years. Meeting the requirements of the entire market while that market was dra- matically increasing proved a challenge. "Benzonatate is a fairly difficult product to manufacture," said Bill Moran, Ascend's Procurement Director. "There are limited DMF's and being a soft gel, the product takes upwards of eight weeks to complete the manufacturing process." Additional API was ordered, which itself needed to be manufactured, and production was ramped up. However, with an eight week lead time, shortages were inevitable. John Dillaway, Ascend's Executive Vice President, states, "It was frustrating because customers were left with the impression that we were not doing a good job of supplying this product, when in reality we were the only company sup- plying, being thrust into a very difficult position." Today, Ascend has dramatically increased its API position and production on Benzonatate. The product is made in the U.S.A. and Ascend is the only company offer- ing all three strengths, including the 100mg, 150mg and 200mg. Dillaway goes on to say, "As the only company that has con- tinuously produced Benzonatate over the past three years and having built up com- fortable inventory positions for the upcoming allergy and cough and cold seasons, we look forward to the opportu- nity to re-engage with customers and dis- cussing how the leading producer of Benzonatate can help them." Visit Ascend at booth #2209.